Olivier Le Tilly

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 4

Top Topics

Cognitive Impairment

Acute Kidney Injury

Top Venues

British journal of clinical pharmacology

Molecular neurobiology

This page only lists publications with an associated author ORCID identifier.

Publications

Olivier Le Tilly, Philippe Gatault, Saida Semlali, Rebecca Sberro-Soussan, Christophe Passot, Dominique Bertrand, Céline Desvignes, Sophie Caillard, Gilles Paintaud, Jean-Michel Halimi, David Ternant
Eculizumab dose tapering should take into account the nonlinearity of its pharmacokinetics. British journal of clinical pharmacology (2024)
Olivier Le Tilly, Philippe Gatault, Saida Semlali, Rebecca Sberro-Soussan, Christophe Passot, Dominique Bertrand, Céline Desvignes, Sophie Caillard, Gilles Paintaud, Jean-Michel Halimi, David Ternant
Eculizumab dose tapering should take into account the nonlinearity of its pharmacokinetics. British journal of clinical pharmacology 90 (5) (2024)
Olivier Le Tilly, Philippe Gatault, Christophe Baron, Theodora Bejan-Angoulvant, Matthias Büchler, Gilles Paintaud, David Ternant
Is CD25 blockade optimal in kidney transplant patients treated with basiliximab? A target-mediated drug disposition model. British journal of clinical pharmacology 88 (7) (2022)
Bérenger Largeau, Olivier Le Tilly, Bénédicte Sautenet, Charlotte Salmon Gandonnière, Chantal Barin-Le Guellec, Stephan Ehrmann
Arginine Vasopressin and Posterior Reversible Encephalopathy Syndrome Pathophysiology: the Missing Link? Molecular neurobiology 56 (10) (2019)